PharmaSGP Aktie
WKN DE: A2P4LJ / ISIN: DE000A2P4LJ5
|
23.04.2025 14:30:08
|
EQS-AFR: PharmaSGP Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
|
EQS Preliminary announcement financial reports: PharmaSGP Holding SE
/ Preliminary announcement on the disclosure of financial statements
PharmaSGP Holding SE hereby announces that the following financial reports shall be disclosed:
Report Type: Annual financial report Language: German Date of disclosure: April 30, 2025 Address: https://ir.pharmasgp.com/#Finanzberichte Language: English Date of disclosure: April 30, 2025 Address: https://ir.pharmasgp.com/en/#FinancialReports Report Type: Annual financial report of the group Language: German Date of disclosure: April 30, 2025 Address: https://ir.pharmasgp.com/#Finanzberichte Language: English Date of disclosure: April 30, 2025 Address: https://ir.pharmasgp.com/en/#FinancialReports
23.04.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | PharmaSGP Holding SE |
| Lochhamer Schlag 1 | |
| 82166 Gräfelfing | |
| Germany | |
| Internet: | https://pharmasgp.com |
| End of News | EQS News Service |
|
|
2122398 23.04.2025 CET/CEST
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu PharmaSGPmehr Nachrichten
Analysen zu PharmaSGPmehr Analysen
Aktien in diesem Artikel
| PharmaSGP | 24,80 | -0,80% |
|
Letzte Top-Ranking Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.